Literature DB >> 16990336

Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.

Hussam Ammar, Ashok K Malani, Chakshu Gupta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16990336      PMCID： PMC1570816          DOI： 10.1136/bmj.333.7569.654

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The prevention of prostate cancer--the dilemma continues.

Authors:  Peter T Scardino
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245

Review 2.  Benign prostatic hyperplasia: treatment in primary care.

Authors:  Anand K Patel; Christopher R Chapple
Journal:  BMJ       Date:  2006-09-09

3.  Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.

Authors:  X J Yang; K Lecksell; K Short; J Gottesman; L Peterson; J Bannow; P F Schellhammer; W P Fitch; G B Hodge; R Parra; S Rouse; J Waldstreicher; J I Epstein
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

4.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.